| Literature DB >> 32466613 |
Michele Ragazzo1, Stefania Carboni2, Valerio Caputo1, Carlotta Buttini1, Laura Manzo1, Valeria Errichiello1, Giulio Puleri1, Emiliano Giardina1,2.
Abstract
Forensic investigation for the identification of offenders, recognition of human remains, and verification of family relationships requires the analysis of particular types of highly informative DNA markers, which have high discriminatory power and are efficient for typing degraded samples. These markers, called STRs (Short Tandem Repeats), can be amplified by multiplex-PCR (Polymerase Chain Reaction) allowing attainment of a unique profile through which it is possible to distinguish one individual from another with a high statistical significance. The rapid and progressive evolution of analytical techniques and the advent of Next-Generation Sequencing (NGS) have completely revolutionized the DNA sequencing approach. This technology, widely used today in the diagnostic field, has the advantage of being able to process several samples in parallel, producing a huge volume of data in a short time. At this time, although default parameters of interpretation software are available, there is no general agreement on the interpretation rules of forensic data produced via NGS technology. Here we report a pilot study aimed for a comparison between NGS (Precision ID GlobalFiler™ NGS STR Panel v2, Thermo Fisher Scientific, Waltham, MA, USA) and traditional methods in their ability to identify major and minor contributors in DNA mixtures from saliva and urine samples. A quantity of six mixed samples were prepared for both saliva and urine samples from donors. A total of 12 mixtures were obtained in the ratios of 1:2; 1:4; 1:6; 1:8; 1:10; and 1:20 between minor and major contributors. Although the number of analyzed mixtures is limited, our results confirm that NGS technology offers a huge range of additional information on samples, but cannot ensure a higher sensitivity in respect to traditional methods. Finally, the Precision ID GlobalFiler™ NGS STR Panel v2 is a powerful method for kinship analyses and typing reference samples, but its use in biological evidence should be carefully considered on the basis of the characteristics of the evidence.Entities:
Keywords: DNA typing; forensic genomics; mixtures; next-generation sequencing (NGS)
Year: 2020 PMID: 32466613 PMCID: PMC7349666 DOI: 10.3390/genes11060591
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Overview of the average DoC for each of the 23 loci regarding buccal swab and urine samples. DoC: Depth of Coverage.
| Locus | Average DoC Buccal Swab | Average DoC Urine Sample |
|---|---|---|
| D3S1358 | 38.7 | 28.7 |
| VWA | 48.6 | 40.5 |
| D16S539 | 64.1 | 63.1 |
| CSF1PO | 68.5 | 46.5 |
| TPOX | 66.2 | 66.8 |
| AMEL | / | / |
| D8S1179 | 32.8 | 28.7 |
| D21S11 | 52.5 | 37.9 |
| DYS391 | 16.3 | 18.3 |
| D2S441 | 53.7 | 55.0 |
| D19S433 | 24.1 | 22.8 |
| TH01 | 75.9 | 106.4 |
| FGA | 29.0 | 20.7 |
| D22S1045 | 46.6 | 55.4 |
| D5S818 | 36.2 | 53.9 |
| D13S317 | 52.0 | 57.2 |
| D7S820 | 51.2 | 42.2 |
| D10S1248 | 25.6 | 26.8 |
| D1S1656 | 34.1 | 31.0 |
| D12S391 | 49.4 | 48.7 |
| D2S1338 | 23.8 | 25.8 |
| YINDEL | / | / |
| D18S51 | 42.8 | 29.3 |
Figure 1Sequence coverage ratios of the buccal swab samples.
Figure 2Sequence coverage ratios of the urine samples.
Figure 3Sequence coverage ratios of the buccal swab mixtures.
Figure 4Sequence coverage ratios of the urine mixtures.
Genotyping results for the buccal swab mixture samples. CE: Capillary Electrophoresis.
| CE Global Filer Mixture DNA Profiles (Buccal Swabs) | |||||||
|---|---|---|---|---|---|---|---|
| Sample | TB_1-2 | TB_1-4 | TB_1-6 | TB_1-8 | TB_1-10 | TB_1-20 | |
| Locus | |||||||
| D3S1358 | 14-16-17-18 | 14-16-17-18 | 14-16-17 | 14-16-17-18 | 14-16-17 | 14-17 | |
| VWA | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | |
| D16S539 | 9-10-11 | 9-10-11 | 9-10-11 | 10-11 | 9-10-11 | 10-11 | |
| CSF1PO | 10-12 | 10- | 10-12 | 10-12 | 10-12 | 10 | |
| TPOX | 8 | 8 | 8 | 8 | 8 | 8 | |
| AMEL | X-Y | X-Y | X-Y | X-Y | X-Y | X-Y | |
| D8S1179 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | |
| D21S11 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | |
| DYS391 | 10 | 10 | 10 | 10 | 10 | 10 | |
| D2S441 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | |
| D19S433 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | |
| TH01 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | 6 | |
| FGA | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22 | |
| D22S1045 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | |
| D5S818 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 10-13 | |
| D13S317 | 8-11-13 | 8-11-13 | 8-11 | 8-11-13 | 8-11 | 8-11 | |
| D7S820 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11 | |
| D10S1248 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | |
| D1S1656 | 12-15-17.3 | 12-15-17.3 | 15-17.3 | 12-15-17.3 | 12-15-17.3 | 15-17.3 | |
| D12S391 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22 | 17-17.3-22-23 | 17-17.3-22 | 17.3-22 | |
| D2S1338 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-25 | |
| YINDEL | 2 | 2 | 2 | 2 | 2 | 2 | |
| D18S51 | 12-13 | 13 | 12-13 | 13 | 13 | 13 | |
Genotyping results for the buccal swab mixture samples. NGS: Next-Generation Sequencing.
| NGS Global Filer Mixture DNA Profiles (Buccal Swabs) | |||||||
|---|---|---|---|---|---|---|---|
| Sample | TB_1-2 | TB_1-4 | TB_1-6 | TB_1-8 | TB_1-10 | TB_1-20 | |
| Locus | |||||||
| D3S1358 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | |
| VWA | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | |
| D16S539 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | |
| CSF1PO | 10-12 | 10- | 10-12 | 10-12 | 10-12 | 10 | |
| TPOX | 8 | 8 | 8 | 8 | 8 | 8 | |
| AMEL | X-Y | X-Y | X-Y | X-Y | X-Y | X-Y | |
| D8S1179 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | |
| D21S11 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | |
| DYS391 | 10 | 10 | 10 | 10 | 10 | 10 | |
| D2S441 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | |
| D19S433 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | |
| TH01 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | |
| FGA | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22 | |
| D22S1045 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | |
| D5S818 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 10-13 | |
| D13S317 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | |
| D7S820 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | |
| D10S1248 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | |
| D1S1656 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | |
| D12S391 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | |
| D2S1338 | 17-21-25 | 17-21-25 | 17-21-25 | 17-25 | 17-21-25 | 17-25 | |
| YINDEL | 2 | 2 | 2 | 2 | 2 | 2 | |
| D18S51 | 12-13 | 12-13 | 12-13 | 12-13 | 12-13 | 12-13 | |
Genotyping results for the urine-mixture samples. CE: Capillary Electrophoresis.
| CE Global Filer Mixture DNA Profiles (Urine) | |||||||
|---|---|---|---|---|---|---|---|
| Sample | UR_1-2 | UR_1-4 | UR_1-6 | UR_1-8 | UR_1-10 | UR_1-20 | |
| Locus | |||||||
| D3S1358 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-17 | |
| VWA | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | |
| D16S539 | 9-10-11 | 9-10-11 | 10-11 | 9-10-11 | 9-10-11 | 10-11 | |
| CSF1PO | 10-12 | 10- | 10-12 | 10 | 10-12 | 10 | |
| TPOX | 8 | 8 | 8 | 8 | 8 | 8 | |
| AMEL | X-Y | X-Y | X-Y | X-Y | X-Y | X-Y | |
| D8S1179 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | |
| D21S11 | 28-29-30 | 28-29-30 | 28-29-30 | 29-30 | 28-29-30 | 28-29-30 | |
| DYS391 | 10 | 10 | 10 | 10 | 10 | 10 | |
| D2S441 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | |
| D19S433 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | |
| TH01 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | |
| FGA | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22-23 | 20-22 | |
| D22S1045 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | |
| D5S818 | 9-10-13 | 9-10-13 | 10-13 | 10-13 | 9-10-13 | 9-10-13 | |
| D13S317 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | |
| D7S820 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | |
| D10S1248 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14 | 13-14-15 | 13-14-15 | |
| D1S1656 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | |
| D12S391 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22 | 17.3-22 | 17-17.3-22-23 | 17.3-22-23 | |
| D2S1338 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | |
| YINDEL | 2 | 2 | 2 | 2 | 2 | 2 | |
| D18S51 | 12-13 | 13 | 12-13 | 13 | 13 | 13 | |
Genotyping results for the urine-mixture samples. NGS: Next-Generation Sequencing.
| NGS Global Filer Mixture DNA Profiles (Urine) | |||||||
|---|---|---|---|---|---|---|---|
| Sample | UR_1-2 | UR_1-4 | UR_1-6 | UR_1-8 | UR_1-10 | UR_1-20 | |
| Locus | |||||||
| D3S1358 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | 14-16-17-18 | |
| VWA | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | 14-17-18 | |
| D16S539 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | 9-10-11 | |
| CSF1PO | 10-12 | 10- | 10-12 | 10-12 | 10-12 | 10-12 | |
| TPOX | 8 | 8 | 8 | 8 | 8 | 8 | |
| AMEL | X-Y | X-Y | X-Y | X-Y | X-Y | X-Y | |
| D8S1179 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | 13-16 | |
| D21S11 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | 28-29-30 | |
| DYS391 | 10 | 10 | 10 | 10 | 10 | 10 | |
| D2S441 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | 10-11 | |
| D19S433 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | 13-14 | |
| TH01 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | 6-9 | |
| FGA | 20-22-23 | 20-22-23 | 20-22 | 20-22-23 | 20-22-23 | 20-22 | |
| D22S1045 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | 15-17 | |
| D5S818 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | 9-10-13 | |
| D13S317 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | 8-11-13 | |
| D7S820 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | 9-11-12 | |
| D10S1248 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | 13-14-15 | |
| D1S1656 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | 12-15-17.3 | |
| D12S391 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | 17-17.3-22-23 | |
| D2S1338 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | 17-21-25 | |
| YINDEL | 2 | 2 | 2 | 2 | 2 | 2 | |
| D18S51 | 12-13 | 12-13 | 12-13 | 12-13 | 12-13 | 12-13 | |
Figure 5(a) Biostatistical and comparative analysis aimed at evaluating the inclusion or exclusion of the major contributor (M) in the mixtures coming from buccal swab sample (semicontinuous method); (b) biostatistical and comparative analyses aimed at evaluating the inclusion or exclusion of the major contributor (M) in the mixtures coming from urine samples (semicontinuous method).
Figure 6(a) Biostatistical and comparative analysis aimed at evaluating the inclusion or exclusion of the minor contributor (m) in the mixtures coming from buccal swab samples (semicontinuous method); (b) biostatistical and comparative analyses aimed at evaluating the inclusion or exclusion of the minor contributor (m) in the mixtures coming from urine samples (semicontinuous method).